WestGene Biopharma has raised $41.8 million in a Series A round, while HongShan-backed SaaS platform Jushuitan has filed for an initial public offering (IPO) in Hong Kong.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
